Cellevate AB and InVitria Inc. enter strategic collaboration to advance upstream bioprocessing solutions for viral vaccine production

LUND, Sweden – March 10, 2026 – Cellevate AB today announces a strategic collaboration agreement with InVitria, Inc., a U.S.-based leader in chemically defined, animal-component-free cell culture media and recombinant protein solutions. The collaboration will execute a joint development program integrating InVitria’s high-performance media with Cellevate’s Cellevat3d® nanofiber microcarrier platform. The program includes microcarrier screening, … Continue reading Cellevate AB and InVitria Inc. enter strategic collaboration to advance upstream bioprocessing solutions for viral vaccine production